Ekso Bionics Holdings Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,301.90
5,327.00
8,661.00
14,221.00
7,353.00
11,332
Cost of Goods Sold (COGS) incl. D&A
3,183.50
3,768.00
7,482.00
10,137.00
5,077.00
7,023
Gross Income
118.40
1,559.00
1,179.00
4,084.00
2,276.00
4,309
SG&A Expense
10,412.70
16,753.00
22,740.00
29,629.00
33,354.00
31,374
EBIT
10,294.30
15,194.00
21,561.00
25,771.00
31,285.00
27,065
Unusual Expense
427.00
18,085.00
2,505.00
2,471.00
2,515.00
1,098
Non Operating Income/Expense
244.00
61.00
532.00
166.00
296.00
425
Interest Expense
927.30
435.00
13.00
16.00
648.00
600
Pretax Income
11,887.40
33,769.00
19,590.00
23,470.00
29,122.00
26,992
Consolidated Net Income
11,887.40
33,769.00
19,590.00
23,470.00
29,122.00
26,992
Net Income
11,887.40
33,769.00
19,590.00
23,470.00
29,122.00
26,992
Net Income After Extraordinaries
11,887.40
33,769.00
19,590.00
23,470.00
29,122.00
26,992
Net Income Available to Common
11,887.40
33,769.00
24,245.00
33,815.00
29,122.00
26,992
EPS (Basic)
-
3.02
1.82
2.05
0.82
0.44
Basic Shares Outstanding
11,211.40
11,180.60
14,605.90
18,126.00
35,609.00
61,229
EPS (Diluted)
1.06
3.02
1.83
2.05
0.82
0.44
Diluted Shares Outstanding
11,211.40
11,180.60
14,609.30
18,622.00
35,609.00
61,229
EBITDA
9,825.40
14,449.00
20,628.00
23,916.00
29,553.00
25,565
Other Operating Expense
-
-
-
226.00
207.00
-
Non-Operating Interest Income
5.20
6.00
11.00
12.00
-
-
Preferred Dividends
-
-
4,655.00
10,345.00
-
-
About Ekso Bionics Holdings
View Profile
